Efficacy outcomes in trials with prophylactic hereditary angioedema therapy: A systematic review

No abstract

Contributors

Remy S. Petersen Lauré M. Fijen Danny M. Cohn

Publication

Journal: Allergy
Volume:
Issue:
Pages: -
Year: 2023
DOI: 10.1111/all.15962

Further Study Information

Current Stage: Completed
Date:
Funding source(s): This research did not receive any specific grant from funding agen-cies in the public, commercial, or not-for-profit sectors.


Health Area

Disease Category: Genetic disorders

Disease Name: Hereditary Angioedema

Target Population

Age Range: Unknown

Sex: Either

Nature of Intervention:

Stakeholders Involved

Study Type

- Systematic review of outcomes measured in trials

Method(s)

- Systematic review

The study was performed in accordance with the PRISMA-P guidelines4 and the protocol was registered in the International Prospective Register of Systematic Reviews (registration number: CRD42022374285). The search syntax for MEDLINE (Table S1) was converted to PubMed and Cochrane Central. These databases were systematically searched from their commencements until November 2022.